Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 1690896, 16 pages
http://dx.doi.org/10.1155/2016/1690896
Research Article

Wnt5a Increases Properties of Lung Cancer Stem Cells and Resistance to Cisplatin through Activation of Wnt5a/PKC Signaling Pathway

1The Center of Laboratory Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China
2Department of Laboratory Medicine, College of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia 750004, China
3College of Life Science, Ningxia University, Yinchuan, Ningxia 750021, China
4Department of Thoracic Surgery of General Hospital, Ningxia Medical University, Yinchuan, Ningxia 750004, China
5Department of Pulmonary and Critical Care Medicine of General Hospital, Ningxia Medical University, Yinchuan 750004, China
6Human Stem Cell Institute of General Hospital, Ningxia Medical University, Yinchuan, Ningxia 750004, China

Received 17 April 2016; Revised 31 August 2016; Accepted 22 September 2016

Academic Editor: Leonard M. Eisenberg

Copyright © 2016 Jiali Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2015,” CA: A Cancer Journal for Clinicians, vol. 65, no. 1, pp. 5–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Han, J. He, F. Li et al., “Emerging roles of MicroRNAs in EGFR-targeted therapies for lung cancer,” BioMed Research International, vol. 2015, Article ID 672759, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. A. K. Dubey, U. Gupta, and S. Jain, “Epidemiology of lung cancer and approaches for its prediction: a systematic review and analysis,” Chinese Journal of Cancer, vol. 35, no. 1, p. 71, 2016. View at Publisher · View at Google Scholar
  4. J. Milanowski and K. Szmygin-Milanowska, “Treatment of non-small cell lung cancer—where we are?” Pneumonologia i Alergologia Polska, vol. 81, no. 1, pp. 55–60, 2013. View at Google Scholar · View at Scopus
  5. L. Yan and L. Xu, “Global efforts in conquering lung cancer in China,” Chinese Journal of Cancer, vol. 34, no. 7, pp. 320–322, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. H. Siddik, “Cisplatin: mode of cytotoxic action and molecular basis of resistance,” Oncogene, vol. 22, no. 47, pp. 7265–7279, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. N. Anastas and R. T. Moon, “WNT signalling pathways as therapeutic targets in cancer,” Nature Reviews Cancer, vol. 13, no. 1, pp. 11–26, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Takebe, L. Miele, P. J. Harris et al., “Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update,” Nature Reviews Clinical Oncology, vol. 12, no. 8, pp. 445–464, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. M. C. Florian, K. J. Nattamai, K. Dörr et al., “A canonical to non-canonical Wnt signalling switch in haematopoietic stem-cell ageing,” Nature, vol. 503, no. 7476, pp. 392–396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Lim and R. Nusse, “Wnt signaling in skin development, homeostasis, and disease,” Cold Spring Harbor Perspectives in Biology, vol. 5, no. 2, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. C. E. Ford, S. S. Qian Ma, A. Quadir, and R. L. Ward, “The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis,” International Journal of Cancer, vol. 133, no. 4, pp. 779–787, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. R. A. Winn, M. Van Scoyk, M. Hammond et al., “Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor γ,” The Journal of Biological Chemistry, vol. 281, no. 37, pp. 26943–26950, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. J. Stewart, D. W. Chang, Y. Ye et al., “Wnt signaling pathway pharmacogenetics in non-small cell lung cancer,” Pharmacogenomics Journal, vol. 14, no. 6, pp. 509–522, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. J. Stewart, “Wnt signaling pathway in non-small cell lung cancer,” Journal of the National Cancer Institute, vol. 106, no. 1, Article ID djt356, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-L. Huang, D. Liu, J. Nakano et al., “Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor—an expression in non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 23, no. 34, pp. 8765–8773, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Lejeune, E. L. Huguet, A. Hamby, R. Poulsom, and A. L. Harris, “Wnt5a cloning, expression, and up-regulation in human primary breast cancers,” Clinical Cancer Research, vol. 1, no. 2, pp. 215–222, 1995. View at Google Scholar · View at Scopus
  17. C. Peng, X. Zhang, H. Yu, D. Wu, and J. Zheng, “Wnt5a as a predictor in poor clinical outcome of patients and a mediator in chemoresistance of ovarian cancer,” International Journal of Gynecological Cancer, vol. 21, no. 2, pp. 280–288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Qi, B. Sun, X. Zhao et al., “Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Cα in epithelial ovarian cancer,” Oncology Reports, vol. 32, no. 2, pp. 771–779, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Saitoh, T. Mine, and M. Katoh, “Frequent up-regulation of WNT5A mRNA in primary gastric cancer,” International Journal of Molecular Medicine, vol. 9, no. 5, pp. 515–519, 2002. View at Google Scholar · View at Scopus
  20. Z. Prgomet, L. Axelsson, P. Lindberg, and T. Andersson, “Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression,” Journal of Oral Pathology and Medicine, vol. 44, no. 10, pp. 776–784, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Qin, Y.-T. Yin, F.-J. Zheng et al., “WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis,” Oncotarget, vol. 6, no. 12, pp. 10239–10252, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Kikuchi, H. Yamamoto, A. Sato, and S. Matsumoto, “Wnt5a: its signalling, functions and implication in diseases,” Acta Physiologica, vol. 204, no. 1, pp. 17–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. M. Whang, U. Jo, J. S. Sung et al., “Wnt5a is associated with cigarette smoke-related lung carcinogenesis via protein kinase C,” PLoS ONE, vol. 8, no. 1, article e53012, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M.-I. L. Kang, A. R. Baker, C. R. Dextras, S. M. Cabarcas, M. R. Young, and N. H. Colburn, “Targeting of noncanonical Wnt5a signaling by AP-1 blocker dominant-negative jun when it inhibits skin carcinogenesis,” Genes and Cancer, vol. 3, no. 1, pp. 37–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Debebe and W. K. Rathmell, “Ror2 as a therapeutic target in cancer,” Pharmacology and Therapeutics, vol. 150, pp. 143–148, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Wu, G. Deng, M. Li et al., “Wnt/β-Catenin signaling reduces Bacillus Calmette-Guerin-induced macrophage necrosis through a ROS -mediated PARP/AIF-dependent pathway,” BMC Immunology, vol. 16, no. 1, article 16, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Fu, Y. Du, C. Yang et al., “An oncogenic role of miR-592 in tumorigenesis of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A),” Expert Opinion on Therapeutic Targets, vol. 20, no. 7, pp. 771–782, 2016. View at Publisher · View at Google Scholar
  28. H. Li, C. Li, R. Dai et al., “Expression of acetylated histone 3 in the spinal cord and the effect of morphine on inflammatory pain in rats,” Neural Regeneration Research, vol. 7, no. 7, pp. 517–522, 2012. View at Google Scholar · View at Scopus
  29. Y. Li, J. Shi, J. Yang et al., “A Wnt/β-catenin negative feedback loop represses TLR-triggered inflammatory responses in alveolar epithelial cells,” Molecular Immunology, vol. 59, no. 2, pp. 128–135, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Bo, L. Gao, Y. Chen, J. Zhang, and M. Zhu, “Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model,” Molecular Medicine Reports, vol. 13, no. 2, pp. 1163–1171, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. L. J. Vuga, A. Ben-Yehudah, E. Kovkarova-Naumovski et al., “WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 5, pp. 583–589, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Katoh and M. Katoh, “STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer (Review),” International Journal of Molecular Medicine, vol. 19, no. 2, pp. 273–278, 2007. View at Google Scholar · View at Scopus
  33. X. Zhang, Y. Lou, H. Wang et al., “Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells,” Medical Oncology, vol. 32, no. 4, article 95, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Pukrop, F. Klemm, T. Hagemann et al., “Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 14, pp. 5454–5459, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. K. Dissanayake and A. T. Weeraratna, “Detecting PKC phosphorylation as part of the Wnt/calcium pathway in cutaneous melanoma,” Methods in Molecular Biology, vol. 468, pp. 157–172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Henry, A. Quadir, N. J. Hawkins et al., “Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling,” Journal of Cancer Research and Clinical Oncology, vol. 141, no. 2, pp. 243–254, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Gao, Z. Liu, X. Zhang et al., “Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells,” Cancer Letters, vol. 336, no. 1, pp. 231–239, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. De, “Wnt/Ca2+ signaling pathway: a brief overview,” Acta Biochimica et Biophysica Sinica, vol. 43, no. 10, pp. 745–756, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Espada, M. B. Calvo, S. Díaz-Prado, and V. Medina, “Wnt signalling and cancer stem cells,” Clinical and Translational Oncology, vol. 11, no. 7, pp. 411–427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Endo, M. Nishita, M. Fujii, and Y. Minami, “Insight into the role of Wnt5a-induced signaling in normal and cancer cells,” International Review of Cell and Molecular Biology, vol. 314, pp. 117–148, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Yuan, C. C. Niu, G. Deng et al., “The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells,” International Journal of Molecular Medicine, vol. 27, no. 1, pp. 63–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Akiri, M. M. Cherian, S. Vijayakumar, G. Liu, A. Bafico, and S. A. Aaronson, “Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma,” Oncogene, vol. 28, no. 21, pp. 2163–2172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Bartis, V. Csongei, A. Weich et al., “Down-regulation of canonical and up-regulation of non-canonical wnt signalling in the carcinogenic process of squamous cell lung carcinoma,” PLoS ONE, vol. 8, no. 3, Article ID e57393, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Nakata, R. Yoshida, R. Yamaguchi et al., “Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs,” Scientific Reports, vol. 5, article 13076, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Li, S. Bellusci, Z. Borok, and P. Minoo, “Non-canonical WNT signalling in the lung,” Journal of Biochemistry, vol. 158, no. 5, pp. 355–365, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. R. J. MacLeod, M. Hayes, and I. Pacheco, “Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 293, no. 1, pp. G403–G411, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Zhu, L. Qin, Z. G. Luo, Q. Guo, L. Y. Yang, and D. F. Liao, “Challenging role of Wnt5a and its signaling pathway in cancer metastasis (Review),” Experimental and Therapeutic Medicine, vol. 8, no. 1, pp. 3–8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. T.-H. Hung, S.-C. Hsu, C.-Y. Cheng et al., “Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway,” Oncotarget, vol. 5, no. 23, pp. 12273–12290, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. T. S. Gujral, M. Chan, L. Peshkin, P. K. Sorger, M. W. Kirschner, and G. Macbeath, “A noncanonical frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis,” Cell, vol. 159, no. 4, pp. 844–856, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Gao, C. Song, L. Hui et al., “Overexpression of RNF146 in non-small cell lung cancer enhances proliferation and invasion of tumors through the wnt/β-catenin signaling pathway,” PLoS ONE, vol. 9, no. 1, Article ID e85377, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Lu, X. Wang, H. Zhu, J. Feng, S. Ni, and J. Huang, “Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer,” Oncotarget, vol. 6, no. 28, pp. 24912–24921, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. M. P. O'Connell, J. L. Fiori, M. Xu et al., “The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma,” Oncogene, vol. 29, no. 1, pp. 34–44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Yao, B. Sun, X. Zhao et al., “Overexpression of Wnt5a promotes angiogenesis in NSCLC,” BioMed Research International, vol. 2014, Article ID 832562, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. S. L. McDonald and A. Silver, “The opposing roles of Wnt-5a in cancer,” British Journal of Cancer, vol. 101, no. 2, pp. 209–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Ying, H. Li, J. Yu et al., “WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/β-catenin signaling, and is frequently methylated in colorectal cancer,” Clinical Cancer Research, vol. 14, no. 1, pp. 55–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. N. Kremenevskaja, R. von Wasielewski, A. S. Rao, C. Schöfl, T. Andersson, and G. Brabant, “Wnt-5a has tumor suppressor activity in thyroid carcinoma,” Oncogene, vol. 24, no. 13, pp. 2144–2154, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Jönsson, J. Dejmek, P.-O. Bendahl, and T. Andersson, “Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas,” Cancer Research, vol. 62, no. 2, pp. 409–416, 2002. View at Google Scholar · View at Scopus
  58. A. Kikuchi and H. Yamamoto, “Tumor formation due to abnormalities in the β-catenin-independent pathway of Wnt signaling,” Cancer Science, vol. 99, no. 2, pp. 202–208, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Huang, G. Liu, B. Zhang, G. Xu, W. Xiong, and H. Yang, “Wnt-5a regulates proliferation in lung cancer cells,” Oncology Reports, vol. 23, no. 1, pp. 177–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Bittner, P. Meltzer, Y. Chen et al., “Molecular classification of cutaneous malignant melanoma by gene expression profiling,” Nature, vol. 406, no. 6795, pp. 536–540, 2000. View at Publisher · View at Google Scholar
  61. S. K. Dissanayake, M. Wade, C. E. Johnson et al., “The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition,” The Journal of Biological Chemistry, vol. 282, no. 23, pp. 17259–17271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Katoh and M. Katoh, “Transcriptional mechanisms of WNT5A based on NF-κB, Hedgehog, TGFβ, and Notch signaling cascades,” International Journal of Molecular Medicine, vol. 23, no. 6, pp. 763–769, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Cortes-Dericks, L. Froment, R. Boesch, R. A. Schmid, and G. Karoubi, “Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity,” BMC Cancer, vol. 14, no. 1, article 304, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. A. L. de Aberasturi, M. Redrado, M. Villalba et al., “TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients,” Cancer Letters, vol. 370, no. 2, pp. 165–176, 2016. View at Publisher · View at Google Scholar · View at Scopus
  65. Z. Li, Y. Xiang, L. Xiang, Y. Xiao, F. Li, and P. Hao, “ALDH maintains the stemness of lung adenoma stem cells by suppressing the notch/CDK2/CCNE pathway,” PLoS ONE, vol. 9, no. 3, Article ID e92669, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Shao, J. P. Sullivan, L. Girard et al., “Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway,” Clinical Cancer Research, vol. 20, no. 15, pp. 4154–4166, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. R. Suresh, S. Ali, A. Ahmad, P. A. Philip, and F. H. Sarkar, “The role of cancer stem cells in recurrent and drug-resistant lung cancer,” Advances in Experimental Medicine and Biology, vol. 890, pp. 57–74, 2016. View at Publisher · View at Google Scholar · View at Scopus
  68. H. Tomita, K. Tanaka, T. Tanaka et al., “Aldehyde dehydrogenase 1A1 in stem cells and cancer,” Oncotarget, vol. 7, no. 10, pp. 11018–11032, 2016. View at Publisher · View at Google Scholar
  69. J. N. Anastas, R. M. Kulikauskas, T. Tamir et al., “WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors,” Journal of Clinical Investigation, vol. 124, no. 7, pp. 2877–2890, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. W. Wei, H.-H. Sun, N. Li et al., “WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells,” Hepatobiliary and Pancreatic Diseases International, vol. 13, no. 5, pp. 529–538, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. A. B. Nagaraj, P. Joseph, O. Kovalenko et al., “Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance,” Oncotarget, vol. 6, no. 27, pp. 23720–23734, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Togashi, H. Hayashi, M. Terashima et al., “Inhibition of β-Catenin enhances the anticancer effect of irreversible EGFR-TKI in EGFR-mutated non-small-cell lung cancer with a T790M mutation,” Journal of Thoracic Oncology, vol. 10, no. 1, pp. 93–101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. J. Zhao, M. Z. Ma, H. Ren et al., “Anti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapy,” Clinical Cancer Research, vol. 19, no. 13, pp. 3567–3576, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. H.-Q. Wang, M.-L. Xu, J. Ma, Y. Zhang, and C.-H. Xie, “Frizzled-8 as a putative therapeutic target in human lung cancer,” Biochemical and Biophysical Research Communications, vol. 417, no. 1, pp. 62–66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Okamoto, T. Hirata, Z. Chen et al., “EMX2 is epigenetically silenced and suppresses growth in human lung cancer,” Oncogene, vol. 29, no. 44, pp. 5969–5975, 2010. View at Publisher · View at Google Scholar · View at Scopus